AB-Biotics is a biotechnology company dedicated to the research, development, production, and global distribution of innovative, scientifically-proven probiotics and other nutraceuticals. Their mission is to improve people's health and wellbeing through evidence-based solutions, focusing on areas such as gastrointestinal health, cardiovascular health, pediatrics, and women's health. Acquired by Kaneka Corporation, AB-Biotics continues to drive innovation in the microbiome space, leveraging its strong R&D capabilities and expanding its international presence.
Serves as the global hub for research and development of novel probiotic strains and nutraceuticals, strategic planning, international business development, and corporate administration for AB-Biotics.
Located within the Parc Tecnològic del Vallès, a science and technology park fostering innovation and collaboration. Likely equipped with advanced R&D laboratories and modern office facilities.
An innovative and scientifically-driven environment, fostering collaboration among researchers, clinicians, and business professionals. Emphasizes quality, efficacy, and a commitment to improving global health. International and dynamic, reflecting its global operations and integration within Kaneka.
The heart of AB-Biotics' scientific discovery and product development, driving its reputation as a leader in evidence-based probiotics. Its location in a technology park supports access to talent, research collaborations, and technological resources.
AB-Biotics' products are available in over 70 countries worldwide. This extensive global reach is supported by a robust network of international partners and distributors, further enhanced by its integration within Kaneka Corporation's global infrastructure. Key functions supported globally include sales and marketing operations, distribution logistics, multinational clinical research collaborations, and technical customer support for their specialized probiotic and nutraceutical solutions across diverse geographic markets.
Av. Universitat Autònoma, 13, Parc Tecnològic del Vallès
Cerdanyola del Vallès
Barcelona
Spain
Address: c/o Kaneka Americas Holding, Inc., 1700 E. Pasadena Fwy, Pasadena, TX 77506, USA
To drive growth and market penetration of AB-Biotics' scientifically validated probiotic strains within the United States and Canadian markets, providing localized expertise, regulatory support, and technical service to B2B customers and partners in the North American region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, AB-BIOTICS' leadership includes:
AB-BIOTICS has been backed by several prominent investors over the years, including:
As a subsidiary of Kaneka Corporation, specific executive team changes within AB-Biotics are not frequently publicized. The core leadership, including co-founders and key directors, has demonstrated stability, focusing on R&D leadership and strategic growth within the Kaneka Probiotics division. No major public announcements regarding hires or exits for AB-Biotics' distinct leadership team have been identified in the last 12 months.
Discover the tools AB-BIOTICS uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
AB-Biotics likely utilizes standard corporate email formats. Common patterns include [first initial][last name]@ab-biotics.com or [first name].[last name]@ab-biotics.com. For general inquiries, the company provides a central email address (info@ab-biotics.com).
[first_initial][last]@ab-biotics.com
Format
jsmith@ab-biotics.com
Example
80%
Success rate
AB-Biotics LinkedIn / Vitafoods Insights • May 16, 2024
AB-Biotics (a Kaneka company) actively participated in Vitafoods Europe 2024, held from May 14-16. The company presented its latest research findings and innovative probiotic solutions, including strains targeting gut health, immunity, and mental wellbeing, engaging with industry partners and highlighting their scientific advancements in the nutraceutical field....more
NutraIngredients.com • February 20, 2024
Kaneka Probiotics, which incorporates the extensive expertise and product lines of AB-Biotics, emphasized its commitment to clinically validated probiotic strains. At an industry event, they showcased solutions targeting a wide array of health applications, from digestive wellness and immune support to cardiovascular health, underscoring the scientific rigor behind their offerings....more
AB-Biotics News • July 26, 2023
AB-Biotics announced the launch of a new probiotic formulation specifically designed to support adult oral health. This new product leverages specific bacterial strains clinically studied for their benefits in maintaining a healthy oral microbiome, preventing cavities, and addressing gum issues....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including AB-BIOTICS, are just a search away.